nach oben

International Journal of Colorectal Disease

Erschienen in:

24.05.2020 | Review

Comparison of the transanal surgical techniques for local excision of rectal tumors: a network meta-analysis

verfasst von: Konstantinos Perivoliotis, Ioannis Baloyiannis, Chamaidi Sarakatsianou, George Tzovaras

Erschienen in: International Journal of Colorectal Disease | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

In order to assess the various surgical modalities for local resection of rectal tumors, a systematic review of the current literature and a network meta-analysis (NMA) was designed and conducted.

Methods

The present study adhered to the PRISMA guidelines and the Cochrane Handbook for Systematic Reviews of Interventions principles. Scholar databases (Medline, Scopus, Web of Science) were systematically screened up to 23/12/2019. A Bayesian NMA, implementing a Markov chain Monte Carlo analysis, was introduced for the probability ranking of the available surgical methods. Odds ratio (OR) and weighted mean difference (WMD) of the categorical and continuous variables, respectively, were reported with the corresponding 95% confidence interval (95%CI).

Results

Overall, 16 studies and 2146 patients were introduced in our study. Transanal minimal invasive surgery (TAMIS) displayed the highest performance regarding the overall postoperative morbidity, the perioperative blood loss, the length of hospitalization, and the peritoneal violation rate. Transanal endoscopic microsurgery (TEM) was the most efficient modality for resecting an intact specimen. Although transanal local excision (TAE) had the highest ranking considering operative duration, it was associated with a significant risk for positive resection margins and tumor recurrence.

Conclusions

In conclusion, TEM and TAMIS display superior oncological results over TAE. Due to several limitations, validation of these results requires further RCTs of a higher methodological level.

Nur mit Berechtigung zugänglich

Heald RJ, Santiago I, Pares O, Carvalho C, Figueiredo N (2017) The perfect total mesorectal excision obviates the need for anything else in the management of most rectal cancers. Clin Colon Rectal Surg 30:324–332. https://doi.org/10.1055/s-0037-1606109CrossRef

Rullier E, Rouanet P, Tuech JJ, Valverde A, Lelong B, Rivoire M, Faucheron JL, Jafari M, Portier G, Meunier B, Sileznieff I, Prudhomme M, Marchal F, Pocard M, Pezet D, Rullier A, Vendrely V, Denost Q, Asselineau J, Doussau A (2017) Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Lancet 390:469–479. https://doi.org/10.1016/S0140-6736(17)31056-5CrossRef

Shaikh I, Askari A, Ouru S et al (2015) Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis. Int J Color Dis 30:19–29. https://doi.org/10.1007/s00384-014-2045-1CrossRef

Kauff DW, Roth YDS, Bettzieche RS, Kneist W (2020) Fecal incontinence after total mesorectal excision for rectal cancer-impact of potential risk factors and pelvic intraoperative neuromonitoring. World J Surg Oncol 18:12. https://doi.org/10.1186/s12957-020-1782-6CrossRef

Pucciarelli S, Giandomenico F, De Paoli A et al (2017) Bowel function and quality of life after local excision or total mesorectal excision following chemoradiotherapy for rectal cancer. Br J Surg 104:138–147. https://doi.org/10.1002/bjs.10318CrossRef

Sterk P, Shekarriz B, Günter S, Nolde J, Keller R, Bruch HP, Shekarriz H (2005) Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision: prospective study on 52 patients. Int J Color Dis 20:423–427. https://doi.org/10.1007/s00384-004-0711-4CrossRef

George D, Pramil K, Kamalesh NP, Ponnambatheyil S, Kurumboor P (2018) Sexual and urinary dysfunction following laparoscopic total mesorectal excision in male patients: a prospective study. J Minim Access Surg 14:111–117. https://doi.org/10.4103/jmas.JMAS_93_17CrossRef

Smith FML, Ahad A, Perez RO, Marks J, Bujko K, Heald RJ (2017) Local excision techniques for rectal cancer after neoadjuvant chemoradiotherapy: what are we doing? Dis Colon Rectum 60:228–239. https://doi.org/10.1097/DCR.0000000000000749CrossRef

Rouleau-Fournier F, Brown CJ (2019) Can less be more? Organ preservation strategies in the management of rectal cancer. Curr Oncol 26:S16–S23CrossRef

10.

Russo S, Anker CJ, Abdel-Wahab M, Azad N, Das P, Dragovic J, Goodman KA, Herman JM, Jones W III, Kennedy T, Konski A, Kumar R, Lee P, Patel NM, Sharma N, Small W, Suh WW, Jabbour SK (2019) Executive summary of the american radium society appropriate use criteria for local excision in rectal cancer. Int J Radiat Oncol Biol Phys 105:977–993CrossRef

11.

Montroni I, Ugolini G, Saur NM, Spinelli A, Rostoft S, Millan M, Wolthuis A, Daniels IR, Hompes R, Penna M, Fürst A, Papamichael D, Desai AM, Cascinu S, Gèrard JP, Myint AS, Lemmens VEPP, Berho M, Lawler M, de Liguori Carino N, Potenti F, Nanni O, Altini M, Beets G, Rutten H, Winchester D, Wexner SD, Audisio RA (2018) Personalized management of elderly patients with rectal cancer: expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Commission on Cancer. Eur J Surg Oncol 44:1685–1702CrossRef

12.

São Julião GP, Celentano JP, Alexandre FA, Vailati BB (2017) Local excision and endoscopic resections for early rectal cancer. Clin Colon Rectal Surg 30:313–323. https://doi.org/10.1055/s-0037-1606108CrossRef

13.

Lai IL, You JF, Chern YJ, Tsai WS, Chiang JM, Hsieh PS, Hung HY, Yeh CY, Chiang SF, Lai CC, Tang RP, Chen JS, Hsu YJ (2019) Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk. World J Surg Oncol 17:212. https://doi.org/10.1186/s12957-019-1763-9CrossRef

14.

Parks AG, Stuart AE (1973) The management of villous tumours of the large bowel. Br J Surg 60:688–695. https://doi.org/10.1002/bjs.1800600908CrossRef

15.

Kidane B, Chadi SA, Kanters S, Colquhoun PH, Ott MC (2015) Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis. Dis Colon Rectum 58:122–140. https://doi.org/10.1097/DCR.0000000000000293CrossRef

16.

Veereman G, Vlayen J, Robays J, Fairon N, Stordeur S, Rolfo C, Bielen D, Bols A, Demetter P, D’hoore A, Haustermans K, Hendlisz A, Lemmers A, Leonard D, Penninckx F, van Cutsem E, Peeters M (2017) Systematic review and meta-analysis of local resection or transanal endoscopic microsurgery versus radical resection in stage i rectal cancer: a real standard? Crit Rev Oncol Hematol 114:43–52. https://doi.org/10.1016/j.critrevonc.2017.03.008CrossRef

17.

Han J, Noh GT, Cheong C, Cho MS, Hur H, Min BS, Lee KY, Kim NK (2017) Transanal endoscopic operation versus conventional transanal excision for rectal tumors: case-matched study with propensity score matching. World J Surg 41:2387–2394. https://doi.org/10.1007/s00268-017-4017-4CrossRef

18.

Buess G, Hutterer F, Theiss J et al (1984) A system for a transanal endoscopic rectum operation. Chirurg 55:677–680

19.

Christoforidis D, Cho H-M, Dixon MR, Mellgren AF, Madoff RD, Finne CO (2009) Transanal endoscopic microsurgery versus conventional transanal excision for patients with early rectal cancer. Ann Surg 249:776–782. https://doi.org/10.1097/SLA.0b013e3181a3e54bCrossRef

20.

Langer C, Liersch T, Suss M et al (2003) Surgical cure for early rectal carcinoma and large adenoma: transanal endoscopic microsurgery (using ultrasound or electrosurgery) compared to conventional local and radical resection. Int J Color Dis 18:222–229. https://doi.org/10.1007/s00384-002-0441-4CrossRef

21.

Moore JS, Cataldo PA, Osler T, Hyman NH (2008) Transanal endoscopic microsurgery is more effective than traditional transanal excision for resection of rectal masses. Dis Colon Rectum 51:1021–1026. https://doi.org/10.1007/s10350-008-9337-xCrossRef

22.

Clancy C, Burke JP, Albert MR, O’Connell PR, Winter DC (2015) Transanal endoscopic microsurgery versus standard transanal excision for the removal of rectal neoplasms: a systematic review and meta-analysis. Dis Colon Rectum 58:254–261. https://doi.org/10.1097/DCR.0000000000000309CrossRef

23.

Mege D, Bridoux V, Maggiori L, Tuech JJ, Panis Y (2017) What is the best tool for transanal endoscopic microsurgery (TEM)? A case-matched study in 74 patients comparing a standard platform and a disposable material. Int J Color Dis 32:1041–1045. https://doi.org/10.1007/s00384-016-2733-0CrossRef

24.

Han Y, He Y, Lin M-B et al (2012) Local resection for rectal tumors: comparative study of transanal endoscopic microsurgery vs. conventional transanal excision - the experience in China. Hepatogastroenterology 59:2490–2493. https://doi.org/10.5754/hge12135CrossRef

25.

Al Bandar MH, Han YD, Razvi SA et al (2017) Comparison of trans-anal endoscopic operation and trans-anal excision of rectal tumors. Ann Med Surg 14:18–24. https://doi.org/10.1016/j.amsu.2016.12.049CrossRef

26.

Serra-Aracil X, Mora-Lopez L, Alcantara-Moral M, Caro-Tarrago A, Navarro-Soto S (2014) Transanal endoscopic microsurgery with 3-D (TEM) or high-definition 2-D transanal endoscopic operation (TEO) for rectal tumors. A prospective, randomized clinical trial. Int J Color Dis 29:605–610. https://doi.org/10.1007/s00384-014-1849-3CrossRef

27.

Thompson EV, Bleier JIS (2017) Transanal minimally invasive surgery. Clin Colon Rectal Surg 30:112–119. https://doi.org/10.1055/s-0036-1597315CrossRef

28.

Clermonts SHEM, van Loon YT, Wasowicz DK, Langenhoff BS, Zimmerman DDE (2018) Comparative quality of life in patients following transanal minimally invasive surgery and healthy control subjects. J Gastrointest Surg 22:1089–1097. https://doi.org/10.1007/s11605-018-3718-9CrossRef

29.

Plummer JM, Leake P-A, Albert MR (2017) Recent advances in the management of rectal cancer: no surgery, minimal surgery or minimally invasive surgery. World J Gastrointest Surg 9:139–148. https://doi.org/10.4240/wjgs.v9.i6.139CrossRef

30.

Kaymak Ş, Sinan H, Saydam M, Aktaş HH, Gecim E, Demirbas S (2019) Comparison of transanal minimally invasive surgery (TAMIS) and transanal endoscopic operations (TEO). Indian J Surg. https://doi.org/10.1007/s12262-019-01943-y

31.

Van den Eynde F, Jaekers J, Fieuws S et al (2019) TAMIS is a valuable alternative to TEM for resection of intraluminal rectal tumors. Tech Coloproctol 23:161–166. https://doi.org/10.1007/s10151-019-01954-7CrossRef

32.

Lee L, Edwards K, Hunter IA, Hartley JE, Atallah SB, Albert MR, Hill J, Monson JR (2017) Quality of local excision for rectal neoplasms using transanal endoscopic microsurgery versus transanal minimally invasive surgery: a multi-institutional matched analysis. Dis Colon Rectum 60:928–935. https://doi.org/10.1097/DCR.0000000000000884CrossRef

33.

Ishikawa K, Arita T, Shimoda K, Hagino Y, Shiraishi N, Kitano S (2005) Usefulness of transanal endoscopic surgery for carcinoid tumor in the upper and middle rectum. Surg Endosc 19:1151–1154. https://doi.org/10.1007/s00464-004-2076-8CrossRef

34.

Melin AA, Kalaskar S, Taylor L, Thompson JS, Ternent C, Langenfeld SJ (2016) Transanal endoscopic microsurgery and transanal minimally invasive surgery: is one technique superior? Am J Surg 212:1063–1067. https://doi.org/10.1016/j.amjsurg.2016.08.017CrossRef

35.

Lebedyev A, Tulchinsky H, Rabau M, Klausner JM, Krausz M, Duek SD (2009) Long-term results of local excision for T1 rectal carcinoma: the experience of two colorectal units. Tech Coloproctol 13:231–236. https://doi.org/10.1007/s10151-009-0521-3CrossRef

36.

de Jong GM, Hugen N (2019) Minimally invasive transanal surgery is safe after incomplete polypectomy of low risk T1 rectal cancer: a systematic review. Color Dis 21:1112–1119. https://doi.org/10.1111/codi.14659CrossRef

37.

Higgins JPT, Cochrane Collaboration (2019) Cochrane handbook for systematic reviews of interventions, 2nd edn. Wiley-Blackwell Publishing Ltd

38.

Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JPA, Straus S, Thorlund K, Jansen JP, Mulrow C, Catalá-López F, Gøtzsche PC, Dickersin K, Boutron I, Altman DG, Moher D (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162:777–784. https://doi.org/10.7326/M14-2385CrossRef

39.

Goossen K, Tenckhoff S, Probst P, Grummich K, Mihaljevic AL, Büchler MW, Diener MK (2018) Optimal literature search for systematic reviews in surgery. Langenbeck's Arch Surg 403:119–129. https://doi.org/10.1007/s00423-017-1646-xCrossRef

40.

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898CrossRef

41.

Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https://doi.org/10.1136/bmj.i4919CrossRef

42.

Uhlmann L, Jensen K, Kieser M (2018) Hypothesis testing in Bayesian network meta-analysis. BMC Med Res Methodol 18:128. https://doi.org/10.1186/s12874-018-0574-yCrossRef

43.

Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13. https://doi.org/10.1186/1471-2288-5-13CrossRef

44.

Caricato M, Borzomati D, Ausania F, Tonini G, Rabitti C, Valeri S, Trodella L, Ripetti V, Coppola R (2006) Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation. Surg Endosc 20:1203–1207. https://doi.org/10.1007/s00464-005-0567-xCrossRef

45.

de Graaf EJR, Burger JWA, van Ijsseldijk ALA et al (2011) Transanal endoscopic microsurgery is superior to transanal excision of rectal adenomas. Color Dis 13:762–767. https://doi.org/10.1111/j.1463-1318.2010.02269.xCrossRef

46.

Winde G, Blasius G, Herwig R, Lügering N, Keller R, Fischer R (1997) Benefit in therapy of superficial rectal neoplasms objectivized: transanal endoscopic microsurgery (TEM) compared to surgical standards. Minim Invasive Ther Allied Technol 6:315–323. https://doi.org/10.3109/13645709709153083CrossRef

47.

Benson AB, Venook AP, Al-Hawary MM et al (2018) Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 16:874–901. https://doi.org/10.6004/jnccn.2018.0061CrossRef

48.

Glynne-Jones R, Wyrwicz L, Tiret E et al (2017) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:iv22–iv40. https://doi.org/10.1093/annonc/mdx224

49.

Rai V, Mishra N (2016) Transanal approach to rectal polyps and cancer. Clin Colon Rectal Surg 29:65–70. https://doi.org/10.1055/s-0035-1570395CrossRef

50.

Ondhia M, Tamvakeras P, O’Toole P et al (2019) Transanal endoscopic microsurgery for rectal lesions in a specialist regional early rectal cancer centre: the Mersey experience. Color Dis 21:1164–1174. https://doi.org/10.1111/codi.14730CrossRef

51.

Barendse RM, Dijkgraaf MG, Rolf UR, Bijnen AB, Consten ECJ, Hoff C, Dekker E, Fockens P, Bemelman WA, de Graaf EJR (2013) Colorectal surgeons’ learning curve of transanal endoscopic microsurgery. Surg Endosc 27:3591–3602. https://doi.org/10.1007/s00464-013-2931-6CrossRef

52.

Westrich G, Venturero M, Schtrechman G, Hazzan D, Khaikin M, Nissan A, Shapiro R, Segev L (2019) transanal minimally invasive surgery for benign and malignant rectal lesions: operative and oncological outcomes of a single center experience. J Laparoendosc Adv Surg Tech A 29:1122–1127. https://doi.org/10.1089/lap.2019.0329CrossRef

53.

Lee L, Kelly J, Nassif GJ, Keller D, Debeche-Adams TC, Mancuso PA, Monson JR, Albert MR, Atallah SB (2018) Establishing the learning curve of transanal minimally invasive surgery for local excision of rectal neoplasms. Surg Endosc 32:1368–1376. https://doi.org/10.1007/s00464-017-5817-1CrossRef

54.

Lopez-Picado A, Albinarrate A, Barrachina B (2017) Determination of perioperative blood loss: Accuracy or approximation? Anesth Analg 125:280–286. https://doi.org/10.1213/ANE.0000000000001992CrossRef

55.

Maslekar S, Pillinger SH, Sharma A, Taylor A, Monson JRT (2007) Cost analysis of transanal endoscopic microsurgery for rectal tumours. Color Dis 9:229–234. https://doi.org/10.1111/j.1463-1318.2006.01132.xCrossRef

56.

Atallah S, Albert M, Larach S (2010) Transanal minimally invasive surgery: a giant leap forward. Surg Endosc 24:2200–2205. https://doi.org/10.1007/s00464-010-0927-zCrossRef

57.

Albert MR, Atallah SB, deBeche-Adams TC et al (2013) Transanal minimally invasive surgery (TAMIS) for local excision of benign neoplasms and early-stage rectal cancer: efficacy and outcomes in the first 50 patients. Dis Colon Rectum 56:301–307. https://doi.org/10.1097/DCR.0b013e31827ca313CrossRef

58.

Hwang Y, Yoon YS, Bong JW, Choi HY, Song IH, Lee JL, Kim CW, Park IJ, Lim SB, Yu CS, Kim JC (2019) Long-term transanal excision outcomes in patients with t1 rectal cancer: comparative analysis of radical resection. Ann Coloproctol 35:194–201. https://doi.org/10.3393/ac.2018.10.18.2CrossRef

59.

Arezzo A, Lo Secco G, Passera R, Esposito L, Guerrieri M, Ortenzi M, Bujko K, Perez RO, Habr-Gama A, Stipa F, Picchio M, Restivo A, Zorcolo L, Coco C, Rizzo G, Mistrangelo M, Morino M (2019) Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study. Tech Coloproctol 23:831–842. https://doi.org/10.1007/s10151-019-02049-zCrossRef

60.

Oh BY, Yun H-R, Kim SH, Yun SH, Kim HC, Lee WY, Chun HK, Cho YB (2015) Features of late recurrence following transanal local excision for early rectal cancer. Dis Colon Rectum 58:1041–1047. https://doi.org/10.1097/DCR.0000000000000456CrossRef

61.

Helewa RM, Rajaee AN, Raiche I, Williams L, Paquin-Gobeil M, Boushey RP, Moloo H (2016) The implementation of a transanal endoscopic microsurgery programme: initial experience with surgical performance. Color Dis 18:1057–1062. https://doi.org/10.1111/codi.13333CrossRef

62.

Caycedo-Marulanda A, Jiang HY, Kohtakangas EL (2017) Transanal minimally invasive surgery for benign large rectal polyps and early malignant rectal cancers: experience and outcomes from the first Canadian centre to adopt the technique. Can J Surg 60:416–423. https://doi.org/10.1503/cjs.002417CrossRef

63.

Marrosu A, Paliogiannis P, Ruggiu MW, Attene F, Trignano M, Scognamillo F (2013) Hybrid transanal endoscopic microsurgery: a novel approach to rectal neoplasm excision. Color Dis 15:e757–e759. https://doi.org/10.1111/codi.12452CrossRef

64.

Spizzirri A, Coccetta M, Cirocchi R, la Mura F, Napolitano V, Bravetti M, Giuliani D, de Sol A, Pressi E, Trastulli S, di Patrizi MS, Avenia N, Sciannameo F (2010) Synchronous colorectal neoplasias: our experience about laparoscopic-TEM combined treatment. World J Surg Oncol 8:105. https://doi.org/10.1186/1477-7819-8-105CrossRef

Titel: Comparison of the transanal surgical techniques for local excision of rectal tumors: a network meta-analysis
verfasst von: Konstantinos Perivoliotis
Ioannis Baloyiannis
Chamaidi Sarakatsianou
George Tzovaras
Publikationsdatum: 24.05.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: International Journal of Colorectal Disease / Ausgabe 7/2020
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-020-03634-7

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich

weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2020

Post-polypectomy surveillance colonoscopy: are we following the guidelines?

Vitamin D regulates claudin-2 and claudin-4 expression in active ulcerative colitis by p-Stat-6 and Smad-7 signaling

Late anastomotic leakage after anal sphincter saving surgery for rectal cancer: is it different from early anastomotic leakage?

Effects of tumor distance from anal verge on survival outcomes for rectal NENs and lymphatic metastasis risk score for colorectal NENs

Laparoscopic versus open selective lateral pelvic lymph node dissection following total mesorectal excision for locally advanced low rectal cancer

Total mesorectal excision with and without lateral lymph node dissection: a systematic review of the literature

Neu im Fachgebiet Chirurgie

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Hinter dieser Appendizitis steckte ein Erreger

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Ureterstriktur: Innovative OP-Technik bewährt sich

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“